JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB203681

Anti-A4GALT antibody

Be the first to review this product! Submit a review

|

(1 Publication)

Rabbit Polyclonal A4GALT antibody. Suitable for IHC-P and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Synthetic Peptide within Human A4GALT aa 250-350 conjugated to Keyhole Limpet Haemocyanin.

View Alternative Names

A14GALT, A4GALT1, A4GALT, Lactosylceramide 4-alpha-galactosyltransferase, Alpha4Gal-T1, CD77 synthase, Globotriaosylceramide synthase, P1/Pk synthase, UDP-galactose:beta-D-galactosyl-beta1-R 4-alpha-D-galactosyltransferase, Gb3 synthase

2 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-A4GALT antibody (AB203681)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-A4GALT antibody (AB203681)

Immunohistochemical analysis of formalin-fixed, paraffin-embedded Human placenta tissue labeling A4GALT using ab203681 at 1/200 dilution.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-A4GALT antibody (AB203681)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-A4GALT antibody (AB203681)

Immunohistochemical analysis of formalin-fixed, paraffin-embedded Human kidney tissue labeling A4GALT using ab203681 at 1/200 dilution.

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IHC-P

applications

Immunogen

Synthetic Peptide within Human A4GALT aa 250-350 conjugated to Keyhole Limpet Haemocyanin. The exact immunogen used to generate this antibody is proprietary information.

Q9NPC4

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/500", "IHCP-species-notes": "<p>When using a fluorescent probe the recommended dilution is 1/50 – 1/200</p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.4 Preservative: 0.02% Proclin 300 Constituents: 50% Glycerol (glycerin, glycerine), 48.98% TBS, 1X, 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

A4GALT also known as Alpha-14-galactosyltransferase or Gb3 synthase is an important enzyme that catalyze the transfer of galactose units to specific lipid and protein receptors. This enzyme has a mass of approximately 43 kDa. A4GALT is mainly expressed in the kidney liver and erythrocytes and it plays a significant role in the formation of glycosphingolipids. The enzyme is integral to cellular recognition and signaling processes due to its activity in glycosphingolipid biosynthesis.
Biological function summary

This enzyme is important for the synthesis of the glycosphingolipid globotriaosylceramide (Gb3). A4GALT acts as part of the glycosphingolipid biosynthesis pathway producing Gb3 by transferring a galactose molecule to lactosylceramide. This process occurs in the Golgi apparatus. A4GALT does not work as part of a larger protein complex but operates efficiently in its monomeric form to fulfill its enzymatic function. Gb3 is especially significant as a component of the plasma membrane influencing cell-cell interactions and signal transduction.

Pathways

A4GALT engages substantially in the glycosphingolipid biosynthesis pathway. It influences metabolic pathways such as the lacto and neolacto series pathways linking it with proteins involved in the synthesis and degradation of cellular components. A prominent protein in these pathways is ceramide glucosyltransferase (UGCG) which precedes A4GALT in the pathway. This relationship involves the production and modification of glycosphingolipids that are important for maintaining cellular homeostasis and intercellular communication.

A4GALT's involvement with Gb3 links it directly to Fabry disease a genetic disorder that results from mutations causing altered Gb3 degradation. Deficiencies in metabolizing Gb3 lead to its accumulation contributing to Fabry disease manifestations. There is also a connection to the Shiga toxin receptor pathway where Gb3 facilitates the binding and entry of the Shiga toxin into cells. Proteins involved in these diseases such as alpha-galactosidase A in Fabry disease further illustrate the significant role A4GALT plays in health and disease by influencing glycosphingolipid metabolism and cellular susceptibility to toxins.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Catalyzes the transfer of galactose from UDP-alpha-D-galactose to lactosylceramide/beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide(d18 : 1(4E)) to produce globotriaosylceramide/globoside Gb3Cer (d18 : 1(4E)) (PubMed : 10748143). Also able to transfer galactose to galactosylceramide/beta-D-Gal-(1<->1')-Cer (PubMed : 10748143). Globoside Gb3Cer is a glycosphingolipid of the globo serie, one of the major types of neutral root structures of glycosphingolipids, that constitute a significant portion of mammalian cell membranes (Probable). Globotriaosylceramide/globoside Gb3Cer in blood and tissue cell membranes is the antigen Pk of blood histogroup P (PubMed : 10747952).. (Microbial infection) Globotriaosylceramide is one of the cellular ligands for bacterial verotoxins.
See full target information A4GALT

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

Physiology international : PubMed35218336

2022

Neuroprotective effect of AGGF1 against isoflurane-induced cognitive dysfunction in aged rats through activating the PI3K/AKT signaling pathways.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaoping Wu,Xuan Zhang,Lei Zhao,Shan Jiang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com